Detalhe da pesquisa
1.
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background.
Am J Hum Genet
; 110(10): 1817-1824, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659414
2.
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research.
Gut
; 73(2): 379-383, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754608
3.
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
BMJ Open
; 14(4): e073639, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631839
4.
Environmental variables and genome-environment interactions predicting IBD diagnosis in large UK cohort.
Sci Rep
; 12(1): 10890, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764673
5.
Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.
Nat Commun
; 12(1): 6702, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795257
6.
Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.
J Exp Med
; 217(2)2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819956